Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes

Surgery Today(2022)10.1007/s00595-021-02343-0Source: DataRank Database

Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes is a research paper published in Surgery Today (2022). On theSindex it has a DataRank of 0.878. It has been cited 21 times, with 13 citing works in its 1-hop citation network.

N/A

0.878DataRank · unranked

Scored on demand from live citation data

21 citations · 13 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 1.96)OA: closedTopics (28)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 53%Citation Network 47%

Base Score Contribution

0.464

From this paper's citation signal

Citation Network Contribution

0.415

From 8 citing papers with measurable signal

Learn more about DataRank methodology →

Authors (5)

Yoko Azuma,Susumu Sakamoto,Sakae Homma,Atsushi Sano,Akira Iyoda

Live enrichment

PubMed:34347162 OpenAlex:https://openalex.org/W3190722030

FWCI

1.96

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

closedLicense: https://www.springer.com/tdm

publisherhttps://link.springer.com/content/pdf/10.1007/s00595-021-02343-0.pdf

publisherhttps://link.springer.com/article/10.1007/s00595-021-02343-0/fulltext.html

journalhttps://doi.org/10.1007/s00595-021-02343-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34347162

Fields of Study

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchOccupational and environmental lung diseasesHumansIdiopathic Pulmonary FibrosisLung Diseases, InterstitialLung NeoplasmsPostoperative PeriodRisk Factors

MeSH Terms

HumansLung NeoplasmsPostoperative PeriodRisk FactorsLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis

Keywords

MedicineIdiopathic pulmonary fibrosisInterstitial lung diseaseExacerbationLung cancerSurgical oncologyUsual interstitial pneumoniaIdiopathic interstitial pneumoniaPulmonary fibrosisLungDiffuse alveolar damageInternal medicineSurgery

Sustainable Development Goals

SDG 0: Good health and well-being

Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes

FAIR Checklist

DataRank Breakdown

Authors (5)

Impact

Open Access

Topics